Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tralokinumab for the Treatment of Atopic Dermatitis.
Freitas E, Guttman-Yassky E, Torres T. Freitas E, et al. Am J Clin Dermatol. 2021 Sep;22(5):625-638. doi: 10.1007/s40257-021-00613-8. Epub 2021 Jun 21. Am J Clin Dermatol. 2021. PMID: 34155602 Review.
Bimekizumab for the Treatment of Psoriasis.
Freitas E, Blauvelt A, Torres T. Freitas E, et al. Drugs. 2021 Oct;81(15):1751-1762. doi: 10.1007/s40265-021-01612-z. Epub 2021 Oct 8. Drugs. 2021. PMID: 34623614 Review.
[Palmoplantar Pustulosis].
Rodrigues MA, Freitas E, Torres T. Rodrigues MA, et al. Among authors: freitas e. Acta Med Port. 2023 Jan 2;36(1):63-64. doi: 10.20344/amp.17018. Epub 2022 Jun 3. Acta Med Port. 2023. PMID: 35657024 Free article. Portuguese. No abstract available.
Bimekizumab for psoriasis.
Rodrigues MA, Freitas E, Torres T. Rodrigues MA, et al. Among authors: freitas e. Drugs Today (Barc). 2022 Jun;58(6):273-282. doi: 10.1358/dot.2022.58.6.3400572. Drugs Today (Barc). 2022. PMID: 35670705
603 results